Calls for papers
-
Submit 500 word abstracts by February 11, 2017. See http://www.inhalationasia.org/conference/inhalation-asia-2017-from-13-to-15-september-2017-in-Hong-Kong/present for a list of topics and submission form. Read more . . .
-
According to numerous sources, Teleflex Medical has voluntarily recalled multiple lots of its LMA MAD intranasal delivery device because the devices are failing to aerosolize the drug. The recall notification says, “Teleflex Medical is recalling… Read more . . .
-
Propeller Health has announced that its inhaler monitoring platform has received 510(k) clearance from the FDA for use with the Ellipta dry powder inhaler. The company had announced a deal with GSK to develop a… Read more . . .
-
Inhaler testing automation company Astech Projects has announced the delivery of a fully automated robotic workstation for shot weight testing of DPIs based on its Xelair 1 Series automation platform. The system rotates each device… Read more . . .
-
Spyryx Biosciences has presented data from preclinical studies of its SPX-101 inhaled SPLUNC1-derived peptide showing that SPX-101 improves mucus clearance and survival in animal models of cystic fibrosis and demonstrated no toxicity. The data were… Read more . . .
-
Connected device company Cohero Health has closed a $9M Series A financing round to fund development of its BreatheSmart platform, business development, and clinical trials, the company said. One of the company’s new investors is… Read more . . .
-
Inhaled drug developer Savara Pharmaceuticals has announced the appointment of former Edgemont Pharmaceuticals CFO David L. Lowrance as its new Chief Financial Officer. Savara cited Lowrance’s experience leading IPOs for Acucela, where he was CFO… Read more . . .
-
Arch Biopartners has announced that Dr. Ralph Panos of the Cincinnati Veterans Affairs Medical Center (CVAMC) will prepare a protocol for human trials of the company’s AB569 inhaled bactericide and will subsequently prepare an application… Read more . . .
-
Upsher-Smith Laboratories has presented data from a Phase 1 study of its USL261 midazolam nasal spray in children with epilepsy demonstrating that the median Tmax for 1.25 mg, 2.5 mg and 5 mg single doses… Read more . . .
-
Fierce Pharma has published a copy of a citizen petition filed by Sandoz that challenges the FDA’s recommendations for establishing bioequivalence for generic copies of Advair Diskus 100/50. The FDA published the draft guidance for… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK